New in vitro phenotypic assay for epilepsy: Fluorescent measurement of synchronized neuronal calcium oscillations

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Pacico, Nathalie ^a   Meur, Ana Mingorance Le ^a  

^a UCB PHARMA   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; 4 AMINOPYRIDINE; AMPA RECEPTOR; BACLOFEN; DIAZEPAM; MAGNESIUM; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; VOLTAGE GATED CALCIUM CHANNEL; VOLTAGE GATED SODIUM CHANNEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CELL CULTURE; CALCIUM SIGNALING; CONTROLLED STUDY; CORTICAL SYNCHRONIZATION; DRUG MECHANISM; EPILEPSY; EPILEPTOGENESIS; HIGH THROUGHPUT SCREENING; IN VITRO STUDY; INTRACELLULAR SIGNALING; MOUSE; NERVE CELL NETWORK; NEUROMODULATION; NONHUMAN; PHENOTYPIC VARIATION; RAT;

ANIMALS; ANTICONVULSANTS; CALCIUM SIGNALING; EPILEPSY; INTRACELLULAR SPACE; ION CHANNELS; LIGANDS; NEURONS; PHENOTYPE; RATS; SPECTROMETRY, FLUORESCENCE;

EID: 84897101125     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0084755     Document Type: Article

References (37)

1. Swinney DC, Anthony J (2011) How were new medicines discovered? Nat Rev Drug Discov 10: 507-519.
2. Eggert US (2013) The why and how of phenotypic small-molecule screens. Nat Chem Biol 9: 206-209.
3. Loscher W, Schmidt D (1988) Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations. Epilepsy Res 2: 145-181.
4. Loscher W, Schmidt D (1994) Strategies in antiepileptic drug development: is rational drug design superior to random screening and structural variation? Epilepsy Res 17: 95-134. (Pubitemid 24076338)
5. Kupferberg H (2001) Animal models used in the screening of antiepileptic drugs. Epilepsia 42 Suppl 4: 7-12.
6. Kobow K, Auvin S, Jensen F, Loscher W, Mody I, et al. (2012) Finding a better drug for epilepsy: antiepileptogenesis targets. Epilepsia 53: 1868-1876.
7. Loscher W, Schmidt D (2006) New Horizons in the development of antiepileptic drugs: Innovative strategies. Epilepsy Res 69: 183-272. (Pubitemid 43796098)
8. Loscher W, Schmidt D (2011) Modern antiepileptic drug development has failed to deliver: ways out of the current dilemma. Epilepsia 52: 657-678. 10.1111/j.1528-1167.2011.03024.x [doi].
9. Galanopoulou AS, Buckmaster PS, Staley KJ, Moshe SL, Perucca E, et al. (2012) Identification of new epilepsy treatments: issues in preclinical methodology. Epilepsia 53: 571-582.
10. Heinemann U, Kann O, Schuchmann S (2006) An Overview of In Vitro Seizure Models in Acute and Organotypic Slices. In: Asla Pitkänen PASaSLM, editors. Models of Seizures and Epilepsy. Elsevier. pp. 35-44.
11. Sombati S, DeLorenzo RJ (1995) Recurrent spontaneous seizure activity in hippocampal neuronal networks in culture. J Neurophysiol 73: 1706-1711.
12. Smetters D, Majewska A, Yuste R (1999) Detecting action potentials in neuronal populations with calcium imaging. Methods 18: 215-221. (Pubitemid 29443837)
13. Arkin MR, Connor PR, Emkey R, Garbison KE, Heinz BA, et al. (2004) FLIPR Assays for GPCR and Ion Channel Targets. NBK92012.
14. Mezler M, Hermann D, Swensen AM, Draguhn A, Terstappen GC, et al. (2012) Development and validation of a fluorescence-based HTS assay for the identification of P/Q-type calcium channel blockers. Comb Chem High Throughput Screen 15: 372-385.
15. Dravid SM, Murray TF (2004) Spontaneous synchronized calcium oscillations in neocortical neurons in the presence of physiological [Mg(2+)]: involvement of AMPA/kainate and metabotropic glutamate receptors. Brain Res 1006: 8-17. (Pubitemid 38392077)
16. Richards GR, Jack AD, Platts A, Simpson PB (2006) Measurement and analysis of calcium signaling in heterogeneous cell cultures. Methods Enzymol 414: 335-347. S0076-6879(06)14019-7
17. Wang X, Gruenstein EI (1997) Mechanism of synchronized Ca2+ oscillations in cortical neurons. Brain Res 767: 239-249. (Pubitemid 27435769)
18. Hemstapat K, Smith MT, Monteith GR (2004) Measurement of intracellular Ca2+ in cultured rat embryonic hippocampal neurons using a fluorescence microplate reader: potential application to biomolecular screening. J Pharmacol Toxicol Methods 49: 81-87. (Pubitemid 38264396)
19. Bacci A, Verderio C, Pravettoni E, Matteoli M (1999) Synaptic and intrinsic mechanisms shape synchronous oscillations in hippocampal neurons in culture. Eur J Neurosci 11: 389-397. (Pubitemid 29050440)
20. Shen M, Piser TM, Seybold VS, Thayer SA (1996) Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures. J Neurosci 16: 4322-4334. (Pubitemid 26243028)
21. Pisani A, Bonsi P, Martella G, De PC, Costa C, et al. (2004) Intracellular calcium increase in epileptiform activity: modulation by levetiracetam and lamotrigine. Epilepsia 45: 719-728. (Pubitemid 38890968)
22. Avoli M, Psarropoulou C, Tancredi V, Fueta Y (1993) On the synchronous activity induced by 4-aminopyridine in the CA3 subfield of juvenile rat hippocampus. J Neurophysiol 70: 1018-1029. (Pubitemid 23289779)
23. Fueta Y, Avoli M (1992) Effects of antiepileptic drugs on 4-aminopyridine-induced epileptiform activity in young and adult rat hippocampus. Epilepsy Res 12: 207-215.
24. LaRoche SM, Helmers SL (2004) The new antiepileptic drugs: scientific review. JAMA 291: 605-614. (Pubitemid 38500315)
25. Rogawski MA, Loscher W (2004) The neurobiology of antiepileptic drugs. Nat Rev Neurosci 5: 553-564. (Pubitemid 38868551)
26. Mangan PS, Kapur J (2004) Factors underlying bursting behavior in a network of cultured hippocampal neurons exposed to zero magnesium. J Neurophysiol 91: 946-957. (Pubitemid 38168864)
27. Blair RE, Deshpande LS, Sombati S, Elphick MR, Martin BR, et al. (2009) Prolonged exposure to WIN55,212-2 causes downregulation of the CB1 receptor and the development of tolerance to its anticonvulsant effects in the hippocampal neuronal culture model of acquired epilepsy. Neuropharmacology 57: 208-218.
28. Arias RL, Bowlby MR (2005) Pharmacological characterization of antiepileptic drugs and experimental analgesics on low magnesium-induced hyperexcitability in rat hippocampal slices. Brain Res 1047: 233-244. (Pubitemid 40803487)
29. Dost R, Rundfeldt C (2000) The anticonvulsant retigabine potently suppresses epileptiform discharges in the low Ca ++ and low Mg++ model in the hippocampal slice preparation. Epilepsy Res 38: 53-66. (Pubitemid 30055316)
30. Straub H, Kohling R, Hohling J, Rundfeldt C, Tuxhorn I, et al. (2001) Effects of retigabine on rhythmic synchronous activity of human neocortical slices. Epilepsy Res 44: 155-165. (Pubitemid 32452225)
31. Gorji A, Hohling JM, Madeja M, Straub H, Kohling R, et al. (2002) Effect of levetiracetam on epileptiform discharges in human neocortical slices. Epilepsia 43: 1480-1487. (Pubitemid 35429764)
32. Lucke A, Musshoff U, Kohling R, Osterfeld M, Mayer T, et al. (1998) Gabapentin potentiation of the antiepileptic efficacy of vigabatrin in an in vitro model of epilepsy. Br J Pharmacol 124: 370-376. (Pubitemid 28248028)
33. DeLorenzo RJ, Sombati S, Coulter DA (2000) Effects of topiramate on sustained repetitive firing and spontaneous recurrent seizure discharges in cultured hippocampal neurons. Epilepsia 41 Suppl 1: S40-S44. (Pubitemid 30202340)
34. Santos SF, Pierrot N, Morel N, Gailly P, Sindic C, et al. (2009) Expression of human amyloid precursor protein in rat cortical neurons inhibits calcium oscillations. J Neurosci 29: 4708-4718.
35. Verderio C, Bacci A, Coco S, Pravettoni E, Fumagalli G, et al. (1999) Astrocytes are required for the oscillatory activity in cultured hippocampal neurons. Eur J Neurosci 11: 2793-2800. (Pubitemid 29364196)
36. Rogawski MA (2006) Molecular targets versus models for new antiepileptic drug discovery. Epilepsy Res 68: 22-28. (Pubitemid 43052773)
37. Loscher W (2002) Animal models of drug-resistant epilepsy. Novartis Found Symp 243: 149-159.